SCHEMBL4569647

SCHEMBL4569647

CC(C)OC(=O)N1CCC(NC(=O)c2cccn2-c2ncc(C(F)(F)F)cc2Cl)CC1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.55
NPSR1 Q6W5P4 1/20 0.55
CYP2C9 P11712 3/20 0.51
CYP2C19 P33261 3/20 0.51
CYP1A2 P05177 1/20 0.51
CYP3A4 P08684 1/20 0.51
MEN1 O00255 3/20 0.51
KMT2A Q03164 3/20 0.51
PPARG P37231 1/20 0.51
NR2E3 Q9Y5X4 1/20 0.51
NCOR2 Q9Y618 1/20 0.51
CNR1 P21554 1/20 0.44
CNR2 P34972 1/20 0.44
GAA P10253 2/20 0.44
PKM P14618 1/20 0.43
ALDH1A1 P00352 2/20 0.42
LMNA P02545 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
CHRM4 P08173 1/20 0.41
KDM4E B2RXH2 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13707643 0.89 MAPT (0.54) MAPTNPSR1CYP2C9CYP2C19CYP1A2
SCHEMBL4565675 0.87 MAPT (0.58) MAPTNPSR1CYP2C9CYP2C19CYP1A2
SCHEMBL4542595 0.84 MAPT (0.47) MAPTNPSR1CYP2C9CYP2C19CYP1A2
SCHEMBL4539869 0.82 MAPT (0.60) MAPTNPSR1CYP2C9CYP2C19CYP1A2
SCHEMBL4569596 0.77 MEN1 (0.55) MAPTNPSR1CYP2C9CYP2C19CYP1A2
SCHEMBL13707529 0.77 KMT2A (0.44) MAPTNPSR1CYP2C9CYP2C19CYP3A4
SCHEMBL4543831 0.76 SMN1; SMN2 (0.51) MAPTNPSR1MEN1KMT2AGAA
SCHEMBL4565632 0.75 MEN1 (0.60) MAPTNPSR1CYP2C9CYP2C19CYP1A2
SCHEMBL4540292 0.74 MAPT (0.64) MAPTNPSR1CYP2C9CYP2C19CYP1A2
SCHEMBL4542879 0.73 MAPT (0.65) MAPTNPSR1CYP2C9CYP2C19CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009117421-A2 HETEROCYCLIC MODULATORS OF GPR119 FOR TREATMENT OF DISEASE KALYPSYS, INC. (US) 2009-09-24 WO disclosed